Clinical Trials Directory

Trials / Completed

CompletedNCT01778465

Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease

Effect of Low Dietary Salicylate on Biochemical Markers of Aspirin Exacerbated Respiratory Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Aspirin-Exacerbated Respiratory Disease, or AERD, consists of aspirin sensitivity, asthma and nasal polyps. It is currently managed by chronic steroid use, multiple endoscopic sinus surgeries and/or aspirin desensitization. However, these treatments have potential adverse effects. A theory has been postulated that decreasing the level of dietary salicylates may help in long-term control of disease. A current trial is in the works to evaluate the clinical outcomes of decreased salicylate, but measurements of biochemical markers of disease has not yet been done. The hypothesis is that decreased dietary salicylates will result in a decrease in urinary salicylates and inflammatory markers of disease, cys-leukotrienes, which are typically elevated in this disease.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLow salicylate dietParticipants followed a 7 days period under a Low salicylate diet
BEHAVIORALNormal DietParticipants followed a 7 days period under a Normal Diet

Timeline

Start date
2013-05-01
Primary completion
2014-03-01
Completion
2014-05-01
First posted
2013-01-29
Last updated
2021-03-09
Results posted
2021-03-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01778465. Inclusion in this directory is not an endorsement.